We are live on
!
Find out more
First Trust Advisors Portfolio holdings
AUM
$140B
1-Year Est. Return
27.84%
This Fund
S&P 500
This Quarter
Est. Return
+7.26%
1 Year Est. Return
+27.84%
3 Year Est. Return
+78.79%
5 Year Est. Return
+98.89%
10 Year Est. Return
+456.9%
AUM
$29.6B
AUM Growth
+$4.22B
(+17%)
Cap. Flow
+$2.91B
Cap. Flow
% of AUM
9.83%
Top 10 Holdings %
Top 10 Hldgs %
7.91%
Holding
2,390
New
174
Increased
1,221
Reduced
844
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
|
+$184M |
| 2 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$158M |
| 3 |
First Trust Health Care AlphaDEX Fund
FXH
|
+$136M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$123M |
| 5 |
First Trust Consumer Staples AlphaDEX Fund
FXG
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$120M |
| 2 |
Conagra Brands
CAG
|
+$72.2M |
| 3 |
IMGN
Immunogen Inc
IMGN
|
+$61.5M |
| 4 |
RAD
Rite Aid Corporation
RAD
|
+$55.9M |
| 5 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$50.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 12.87% |
| 3 | Consumer Discretionary | 10.2% |
| 4 | Consumer Staples | 9.25% |
| 5 | Industrials | 7.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPLS
76
DELISTED
Staples Inc
SPLS
| $73.7M | 0.25% |
4,067,631
+30,883
| +0.8% | +$431K |
|
77
HCA Healthcare
HCA
$83.5B
| $73.4M | 0.25% |
1,000,228
-157,896
| -14% | -$11.1M |
|
|
CPHD
78
DELISTED
Cepheid Inc
CPHD
| $72.5M | 0.24% |
1,338,221
-290,260
| -18% | -$14.7M |
|
79
American Electric Power
AEP
$73.4B
| $72.1M | 0.24% |
1,186,918
+353,983
| +42% | +$20.3M |
|
|
EXAS
80
DELISTED
Exact Sciences
EXAS
| $71.8M | 0.24% |
2,615,338
-1,568,180
| -37% | -$38.2M |
|
|
WBA
81
DELISTED
Walgreens Boots Alliance
WBA
| $71.5M | 0.24% |
938,255
-284,185
| -23% | -$19M |
|
|
AET
82
DELISTED
Aetna Inc
AET
| $70.7M | 0.24% |
796,049
+26,595
| +3% | +$2.23M |
|
|
AGN
83
DELISTED
Allergan plc
AGN
| $70.4M | 0.24% |
273,613
-8,021
| -3% | -$2M |
|
84
Universal Health Services
UHS
$9.16B
| $69.1M | 0.23% |
621,233
+16,122
| +3% | +$1.69M |
|
85
McKesson
MCK
$96.5B
| $68.6M | 0.23% |
330,694
-152
| -0% | -$30.9K |
|
86
HP
HPQ
$22.4B
| $67.5M | 0.23% |
3,703,015
-269,781
| -7% | -$4.52M |
|
|
PDLI
87
DELISTED
PDL BioPharma, Inc.
PDLI
| $67M | 0.23% |
8,691,598
+7,591,489
| +690% | +$60.1M |
|
88
Edwards Lifesciences
EW
$48.3B
| $66.9M | 0.23% |
3,151,632
-286,884
| -8% | -$5.76M |
|
89
Centene
CNC
$31.5B
| $66.6M | 0.22% |
2,566,112
-147,708
| -5% | -$3.45M |
|
90
DaVita
DVA
$15B
| $66.6M | 0.22% |
878,733
+198,515
| +29% | +$14.9M |
|
|
K
91
DELISTED
Kellanova
K
| $66.3M | 0.22% |
1,078,939
+151,983
| +16% | +$9.13M |
|
|
LO
92
DELISTED
LORILLARD INC COM STK
LO
| $66M | 0.22% |
1,048,222
-265,114
| -20% | -$16.4M |
|
93
Entergy
ETR
$54B
| $65.4M | 0.22% |
1,495,052
+674,206
| +82% | +$28M |
|
|
GAS
94
DELISTED
AGL Resources Inc
GAS
| $65.2M | 0.22% |
1,195,830
+605,569
| +103% | +$32M |
|
|
TWTR
95
DELISTED
Twitter, Inc.
TWTR
| $65.1M | 0.22% |
1,814,962
+429,486
| +31% | +$18.3M |
|
|
AGN
96
DELISTED
Allergan Inc
AGN
| $64.4M | 0.22% |
303,041
-60,555
| -17% | -$12M |
|
|
MNK
97
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $64.4M | 0.22% |
650,533
-548,366
| -46% | -$50.4M |
|
|
GRFS
98
Grifois
GRFS
$5.13B
| $64.1M | 0.22% |
3,773,236
+3,725,808
| +7,856% | +$64.1M |
|
|
RAI
99
DELISTED
Reynolds American Inc
RAI
| $63.5M | 0.21% |
1,977,322
-316,726
| -14% | -$10M |
|
100
J.M. Smucker
SJM
$12.4B
| $63.2M | 0.21% |
625,951
+100,017
| +19% | +$10.1M |
|
Similar funds
DAM
First Trust Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, First Trust Advisors held 2,390 positions worth $29.6B, up 17% from $25.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
First Trust Advisors deployed $2.91B of net new capital in Q4 2014, opening 174 new positions and adding to 1,221 existing holdings. Its largest new stake was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $120M trimmed.
- First Trust Advisors's largest Q4 2014 buy was Alnylam Pharmaceuticals: 857,683 shares worth $83.2M.
- First Trust Advisors added most to First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF in Q4 2014, an estimated $184M increase.
- First Trust Advisors's biggest Q4 2014 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $120M.
- First Trust Advisors fully exited Immunogen Inc in Q4 2014, selling an estimated $61.5M.
- First Trust Advisors's ten largest holdings make up 7.9% of its $29.6B portfolio in Q4 2014.
- First Trust Advisors opened 174 new positions and closed 147 in Q4 2014.
- First Trust Advisors's portfolio value rose 17% quarter-over-quarter to $29.6B.
Based on First Trust Advisors's 13F filing for Q4 2014, filed 13 Feb 2015.